Sort
51,593 grants matching “hepatitis”
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse
$759,543Douglas K Owens · Stanford University · R37 · FY2024 · DA
NIDA Clinical Trials Network: Greater New York Node
$759,467John P Rotrosen · New York University School Of Medicine · UG1 · FY2019 · DA
Pan-Genomic Approaches for Comprehensive Blood Screening of Novel or Emerging Infectious Agents
$759,408Charles Yen Chiu · University Of California, San Francisco · R01 · FY2019 · HL
Characterization of Mucosal Lymphocytes
$759,212Richard S Blumberg · Brigham And Women'S Hospital · R37 · FY2012 · DK
Characterization of Mucosal Lymphocytes
$759,212Richard S Blumberg · Brigham And Women'S Hospital · R37 · FY2014 · DK
Hydrogen Sulfide and GLP-1 Combination Therapy to Treat HFpEF
$759,206David Joseph Lefer · Cedars-Sinai Medical Center · R01 · FY2025 · HL
Engineering Multicellular Tissue Structure, Function, and Vascularization
$759,128Christopher S Chen · Boston University (Charles River Campus) · R01 · FY2018 · EB
Indiana University Center for Pediatric Pharmacology
$758,925Jamie L Renbarger · Indiana University Indianapolis · U54 · FY2015 · HD
Mechanisms for regulation of a novel class of anti-diabetic lipids
$758,791Barbara B Kahn · Beth Israel Deaconess Medical Center · R01 · FY2023 · DK
Durban International Clinical Trials Unit
$758,768Umesh G Lalloo · Ukzn Innovation · UM1 · FY2012 · AI
The Epidemiology of the Weiss Cohort Project
$758,753Stanley H Weiss · Rbhs-New Jersey Medical School · R01 · FY2022 · DA
Mechanism of cold platelet clearance
$758,737John H Hartwig · Immune Disease Institute, Inc. · P01 · FY2008 · HL
Immune response to COVID-19 vaccine in HIV infected men and women
$758,692Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI
Developmental Core
$758,666Herman F. Staats · Duke University · P30 · FY2022 · AI
Antisense Mediated Treatment of Hepatitis B Virus Infection
$758,650Urtzi Garaigorta · Scripps Research Institute, The · R01 · FY2014 · AI
Characterization of Mucosal Lymphocytes
$758,526Richard S Blumberg · Brigham And Women'S Hospital · R37 · FY2011 · DK
T cell Immunity and the Outcome of Acute HCV Infection
$758,458Christopher M. Walker · Research Inst Nationwide Children'S Hosp · R01 · FY2017 · AI
Colorado Hepatitis C Cooperative Research Center
$758,229Hugo R Rosen · University Of Colorado Denver · U19 · FY2011 · AI
MRI Assessment of Hip Fracture Risk and Therapy Response in HIV/HCV Coinfection
$758,147Chamith Sudesh Rajapakse · University Of Pennsylvania · R01 · FY2019 · AR
Optimization of the engineered 3D hepatic microenvironment enhances pluripotent stem cell derived hepatocyte
$758,146Robert E Schwartz · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · DK
Technical Validation of MRI Biomarkers of Liver Fat
$758,139Claude B Sirlin · University Of California, San Diego · R01 · FY2010 · DK
Lentiviral Vector-Based Gene Therapy and The Host Genetic Background
$758,060Tal Kafri · Univ Of North Carolina Chapel Hill · R01 · FY2018 · HL
Lentiviral Vector-Based Gene Therapy and The Host Genetic Background
$758,060Tal Kafri · Univ Of North Carolina Chapel Hill · R01 · FY2015 · HL
Lentiviral Vector-Based Gene Therapy and The Host Genetic Background
$758,060Tal Kafri · Univ Of North Carolina Chapel Hill · R01 · FY2017 · HL
Lentiviral Vector-Based Gene Therapy and The Host Genetic Background
$758,060Tal Kafri · Univ Of North Carolina Chapel Hill · R01 · FY2016 · HL